| Overview |
| bsm-90005r-50µL |
| MAP1LC3A Recombinant Antbody Kit (KD-Validated) |
| WB, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human MAP1LC3A |
| 1-34/121 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 84557 |
| Q9H492 |
| MAP1LC3A; Microtubule Associated Protein 1 Light Chain 3 Alpha; MAP1BLC3; MAP1ALC3; ATG8E; LC3A; LC3; Microtubule-Associated Proteins 1A/1B Light Chain 3A; Autophagy-Related Ubiquitin-Like Modifier LC3 A; MAP1 Light Chain 3-Like Protein 1; MAP1A/MAP1B Light Chain 3 A; MAP1A/MAP1B LC3 A; Microtubule-Associated Protein 1 Light Chain 3 Alpha; Microtubule-Associated Proteins 1A/1B Light Chain 3; Autophagy-Related Protein LC3 A; MAP1A/1B Light Chain 3 A |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| IC |
1:1000 |